Aetna Inc. (NYSE:AET) was downgraded by research analysts at BidaskClub from a “buy” rating to a “hold” rating in a report issued on Monday, July 31st.

Other research analysts have also issued research reports about the stock. Stifel Nicolaus reaffirmed a “buy” rating and set a $150.00 target price (up previously from $130.00) on shares of Aetna in a research note on Wednesday, May 3rd. Zacks Investment Research raised shares of Aetna from a “hold” rating to a “buy” rating and set a $143.00 target price for the company in a research note on Tuesday, April 4th. Royal Bank Of Canada reaffirmed a “buy” rating and set a $145.00 target price on shares of Aetna in a research note on Monday, April 24th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $150.00 target price on shares of Aetna in a research note on Friday, May 12th. Finally, Cleveland Research raised shares of Aetna from a “neutral” rating to a “buy” rating in a research note on Thursday, May 11th. Eight analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $157.09.

Shares of Aetna (AET) traded down 0.18% during trading on Monday, hitting $152.15. The stock had a trading volume of 1,791,311 shares. The stock has a 50 day moving average of $154.26 and a 200 day moving average of $139.02. Aetna has a 52-week low of $104.59 and a 52-week high of $161.69. The firm has a market cap of $50.53 billion, a PE ratio of 33.77 and a beta of 0.54.

Aetna (NYSE:AET) last released its quarterly earnings data on Thursday, August 3rd. The company reported $3.42 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.34 by $1.08. The firm had revenue of $15.52 billion during the quarter, compared to analysts’ expectations of $15.34 billion. Aetna had a net margin of 2.52% and a return on equity of 20.52%. Aetna’s revenue was down 2.7% compared to the same quarter last year. During the same period last year, the business earned $2.21 earnings per share. On average, equities analysts anticipate that Aetna will post $9.52 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “Aetna Inc. (AET) Downgraded by BidaskClub” was originally reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. & international trademark & copyright legislation. The original version of this piece can be read at https://theolympiareport.com/2017/08/12/aetna-inc-aet-cut-to-hold-at-bidaskclub-updated.html.

In other Aetna news, Chairman Mark T. Bertolini sold 103,547 shares of the stock in a transaction on Wednesday, May 17th. The stock was sold at an average price of $140.79, for a total value of $14,578,382.13. Following the sale, the chairman now directly owns 659,888 shares of the company’s stock, valued at $92,905,631.52. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Margaret M. Mccarthy sold 27,028 shares of the stock in a transaction on Wednesday, June 7th. The stock was sold at an average price of $149.23, for a total value of $4,033,388.44. Following the completion of the sale, the executive vice president now directly owns 33,563 shares in the company, valued at $5,008,606.49. The disclosure for this sale can be found here. 0.90% of the stock is owned by corporate insiders.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Guardian Life Insurance Co. of America raised its position in shares of Aetna by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock worth $173,000 after buying an additional 9 shares during the period. Concert Wealth Management Inc. raised its position in shares of Aetna by 0.4% in the first quarter. Concert Wealth Management Inc. now owns 3,262 shares of the company’s stock worth $405,000 after buying an additional 14 shares during the period. CAPROCK Group Inc. raised its position in shares of Aetna by 0.9% in the first quarter. CAPROCK Group Inc. now owns 2,824 shares of the company’s stock worth $360,000 after buying an additional 25 shares during the period. Rehmann Capital Advisory Group raised its position in shares of Aetna by 1.1% in the first quarter. Rehmann Capital Advisory Group now owns 2,335 shares of the company’s stock worth $298,000 after buying an additional 25 shares during the period. Finally, Geneva Advisors LLC raised its position in shares of Aetna by 1.0% in the first quarter. Geneva Advisors LLC now owns 2,588 shares of the company’s stock worth $330,000 after buying an additional 25 shares during the period. 91.73% of the stock is currently owned by institutional investors.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Analyst Recommendations for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.